← Open Payments lookup

TIMOTHY FURLONG: Open Payments

NPI 1629044557 · ATHENS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,556 in 82 payments from 13 companies in 2025. Trend: 2023 $1,169 · 2024 $1,253 · 2025 $1,556

Food & beverage: $1,556
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.14$347
ABBVIE INC.20$269
E.R. Squibb & Sons, L.L.C.12$174
Neurocrine BioSciences, Inc.8$172
Alkermes, Inc.8$135
Otsuka America Pharmaceutical, Inc.4$111
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$107
Lundbeck LLC4$90
Teva Pharmaceuticals USA, Inc.3$67
Janssen Pharmaceuticals, Inc1$24

Products named: FANAPT, VRAYLAR, COBENFY, INGREZZA, REXULTI, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.